acetylleucyl-leucyl-norleucinal has been researched along with ro 13-6298 in 1 studies
Studies (acetylleucyl-leucyl-norleucinal) | Trials (acetylleucyl-leucyl-norleucinal) | Recent Studies (post-2010) (acetylleucyl-leucyl-norleucinal) | Studies (ro 13-6298) | Trials (ro 13-6298) | Recent Studies (post-2010) (ro 13-6298) |
---|---|---|---|---|---|
321 | 0 | 53 | 53 | 2 | 0 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Breen, SA; Clarkson, PN; Johnstone, D; Loveday, BE; Millest, AJ; Simpson, CA; Waterton, JC | 1 |
1 other study(ies) available for acetylleucyl-leucyl-norleucinal and ro 13-6298
Article | Year |
---|---|
Effects of an inhibitor of cathepsin L on bone resorption in thyroparathyroidectomized and ovariectomized rats.
Topics: Animals; Benzoates; Bone Resorption; Cathepsin L; Cathepsins; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Disease Models, Animal; Endopeptidases; Female; Humans; Hypercalcemia; Leupeptins; Male; Osteoporosis; Ovariectomy; Ovary; Parathyroid Glands; Parathyroidectomy; Rats; Rats, Wistar; Retinoids; Thyroid Gland; Thyroidectomy | 1997 |